SCHEMBL8701093

SCHEMBL8701093

CCCCC1NC(C(=O)OCC)=C(Cl)N1C.CCOC(=O)C1(c2cccs2)CC=CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.38
ADORA2B P29275 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KMT2A Q03164 1/20 0.37
TSHR P16473 4/20 0.34
LMNA P02545 2/20 0.34
KDM4E B2RXH2 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MAPT P10636 2/20 0.34
TP53 P04637 1/20 0.34
OPRM1 P35372 2/20 0.33
POLB P06746 1/20 0.32
USP2 O75604 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTR1E P28566 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL244317 0.76 OPRM1 (0.43) PKMADORA2BALDH1A1KMT2ATSHR
SCHEMBL8704429 0.76 KDM4E (0.35) ALDH1A1TSHRKDM4EHSD17B10OPRM1
SCHEMBL8701089 0.66 OPRM1 (0.31) OPRM1
SCHEMBL1428238 0.65 OPRM1 (0.44) ALDH1A1LMNAKDM4EMAPTTP53
SCHEMBL7415776 0.65 CHRM3 (0.51) TSHRLMNATP53OPRM1SMN1; SMN2
SCHEMBL4861464 0.64 ALDH1A1 (0.41) ALDH1A1TSHRLMNAKDM4EHPGD
SCHEMBL7421543 0.64 OPRM1 (0.47) LMNAHSD17B10TP53OPRM1SMN1; SMN2
SCHEMBL1428246 0.64 CHRM3 (0.53) TSHRLMNATP53OPRM1SMN1; SMN2
SCHEMBL7414392 0.64 CHRM3 (0.53) TSHRLMNATP53OPRM1SMN1; SMN2
SCHEMBL7425414 0.62 TP53 (0.58) ALDH1A1KMT2ALMNAKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5789415-A Azacyclic-heterocyclic compounds as angiotension II receptor antagonists PFIZER INC. (US) 1998-08-04 US disclosed